Research Topics
Genomes and GenesSpecies | Andreas PfutznerSummaryAffiliation: Institute for Clinical Research and Development Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skillsAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 6:910-6. 2012..This study was performed to investigate the impact of dexterity impairment on patient preference for two insulin pen injection devices (InnoLet and FlexTouch)...
Clinical assessment of the accuracy of blood glucose measurement devicesAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Curr Med Res Opin 28:525-31. 2012..BGStar and iBGStar are employ dynamic electrochemistry, which is supposed to result in highly accurate results...
Self-assessment and objective determination of dexterity in patients with type 1 or type 2 diabetes mellitusAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Curr Med Res Opin 28:15-21. 2012....
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: theMarkolf Hanefeld
GWT TUD mbH, Fiedlerstr 34, 01307 Dresden, Germany
Cardiovasc Diabetol 10:65. 2011..We analyzed specific effects of an add-on therapy with pioglitazone compared to metformin and their combination in patients with basal insulin treatment on biomarkers of CV risk...
Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim studyAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 12:599-604. 2010....
Pulmonary insulin delivery by means of the Technosphere drug carrier mechanismAndreas Pfutzner
Institute for Clinical Research and Development, Parcusstr 8, D 55116 Mainz, Germany
Expert Opin Drug Deliv 2:1097-106. 2005..Provided a reliable long-term safety profile, TI may become a suitable alternative to subcutaneous injection for prandial insulin delivery. TI offers the possibility of new treatment regimens, especially in patients with Type 2 diabetes...
Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepirideAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Metabolism 55:20-5. 2006..In conclusion, our short-term investigation of rosiglitazone action provides further experimental support for the rationale of combining rosiglitazone with sulfonylurea drugs in patients with type 2 diabetes...
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitusAndreas Pfutzner
University of Applied Sciences, Rheinbach, Germany
Diabetes Technol Ther 8:28-36. 2006..Positive results in these trials will further strengthen the value and acceptance of hsCRP, which is recommended as a predictive laboratory marker for cardiovascular disease risk also in patients with diabetes mellitus...
Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortalityAndreas Pfutzner
Institut für Klinische Forschung und Entwicklung IKFE, Institute for Clinical Research and Development, Parcusstr 8, D 55116 Mainz, Germany
Expert Opin Pharmacother 7:463-76. 2006..Because of its additional microvascular and macrovascular effects, pioglitazone is an attractive and effective treatment option for the management of Type 2 diabetes mellitus...
Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitusAndreas Pfutzner
Institute for Clinical Research and Development, IKFE GmbH, Parcusstrasse 8, 55116 Mainz, Germany
Clin Chem Lab Med 44:556-60. 2006..Type 2 diabetes mellitus is associated with increased cardiovascular risk. One laboratory marker for cardiovascular risk assessment is high-sensitivity C-reactive protein (hsCRP)...
The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitusAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 8:375-84. 2006..Supplementary insulin therapy provides assistance to meal-time insulin secretion in patients with type 2 diabetes and may have protective effects on beta-cell function...
FlexPen for the delivery of insulin: accuracy, injection force and patient preferenceAndreas Pfutzner
Pfützner Institute for Clinical Research and Development, Mainz, Germany
Expert Rev Med Devices 6:115-23. 2009..Current evidence suggests that FlexPen and Next Generation FlexPen are an attractive choice when considering insulin-delivery methods...
High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 4:706-16. 2010....
Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effectsAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Parcusstr 8 D 55116 Mainz, Germany
Expert Rev Cardiovasc Ther 4:445-59. 2006..These results underline the value of pioglitazone for managing the increased cardiovascular risk of patients with a metabolic syndrome or Type 2 diabetes mellitus...
A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitusAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 54:485-90. 2008....
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combinationAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Vasc Health Risk Manag 3:211-20. 2007..The purpose of this review is to evaluate the clinical data that have been published on this combination, appearing to represent a convenient way to obtain therapeutic targets in patients with type 2 diabetes mellitus...
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effectsAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Expert Opin Pharmacother 8:1985-98. 2007..They underline the value of this drug when used alone or in combination with other antidiabetic drugs for a successful management of Type 2 diabetes mellitus...
Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat studyAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 55:275-81. 2009..We evaluated the plausibility of results derived from a new ELISA (Immundiagnostik, Bensheim, Germany) in comparison to a different ELISA test (Mercodia, Uppsala, Sweden)...
PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemiaAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 13:637-43. 2011..The aim of our study was to investigate the effect of a fixed pioglitazone + metformin (PM) combination (vs. glimepiride + metformin [GM]) on diabetic dyslipidemia...
Analysis of the environmental impact of insulin infusion sets based on loss of resources with wasteAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:843-7. 2011..The loss or resources with regular CSII is considerably lower than the loss or resources induced by patch pumps...
Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery diseaseA Pfutzner
IKFE Institute for Clinical Research and Development Mainz, Germany
Clin Lab 54:237-41. 2008..Visfatin secretion is not regulated by PPARgamma and further research is required to investigate its role in insulin resistance...
Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazoneAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:784-93. 2011....
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitusAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:405-12. 2004..Assessment of beta-cell function by determination of intact proinsulin may facilitate the selection of the most promising therapy and may also serve to monitor treatment success in the further course of the disease...
Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid)Andreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 49:227-32. 2003..In general, the new LIAISON chemiluminescence assay compared favorably with the RIA and comparative chemiluminescence test and offers an attractive alternative for C-peptide analysis...
[Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus]A Pfutzner
Institut für klinische Forschung und Entwicklung, Mainz D
Schweiz Med Wochenschr 130:1854-61. 2000..Since the successful development of devices for continuous glucose monitoring, the development of closed-loop systems has become more and more the focus of current clinical and technological research...
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetesAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Care 27:682-7. 2004..This investigation explored the predictive value of intact proinsulin as an insulin resistance marker...
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistanceAndreas Pfutzner
Institute of Clinical Research and Development, IKFE GmbH, Mainz, Germany
Clin Lab 49:571-6. 2003..It may, however, be concluded from this study that at least in cross-sectional epidemiological investigations, fasting human resistin concentrations are not significantly correlating with any clinical measure for insulin resistance...
Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitusA Pfutzner
Endocrine Research Laboratory ELAB, University Hospital Mainz, Germany
Clin Lab 46:275-9. 2000..Increased measurement of the diabetes-associated antibodies will be helpful in the differential diagnosis of gestational diabetes mellitus (GDM) and latent autoimmune diabetes of the adult (LADA)...
Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulinAndreas Pfutzner
IKFE, Institute of Clinical Research and Development, Mainz, Germany
Clin Chem Lab Med 41:1234-8. 2003..Both CLIAs could be performed much faster (4 hours) than the RIA method (75 hours/ 4 days). In conclusion, the CLIA methods show improved qualitative outcomes, higher specificity and several technical advantages over the RIA method...
Pilot study with technosphere/PTH(1-34)--a new approach for effective pulmonary delivery of parathyroid hormone (1-34)A Pfutzner
MannKind Biopharmaceuticals, 1 Casper Street, Danbury, CT, USA
Horm Metab Res 35:319-23. 2003..In conclusion, pulmonary application of Technosphere/PTH(1 - 34) appears to be an effective and thus attractive candidate for PTH substitution therapy in osteoporosis and other conditions leading to a decrease in bone mineral density...
Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary routeAndreas Pfutzner
Pharmaceutical Discovery Corporation, A MannKind Company, Danbury, Connecticut, USA
Diabetes Technol Ther 4:589-94. 2002..c. injection for prandial insulin delivery, especially in patients with Type 2 diabetes, if the long-term safety, tolerability, and efficacy of this pulmonary insulin are established and confirmed in future studies...
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoringAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:435-41. 2004..Well-educated patients might be the best candidates for first using the device for continuous glucose monitoring. They may especially benefit from the trend indication and the hypoglycemia/hyperglycemia threshold and alarm functions...
Cross-sectional investigation on the accuracy of alternate site glucose testing using the Soft-Sense glucose meterAndreas Pfutzner
Institut für klinische Forschung und Entwicklung, Mainze
Swiss Med Wkly 132:351-7. 2002....
Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose controlA Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
Horm Metab Res 37:510-5. 2005..Adiponectin, intact proinsulin, and the IRIS-II score may be suitable parameters for monitoring of these additional beneficial therapeutic effects...
Clinical and laboratory evaluation of a new specific ELISA for intact proinsulinA Pfutzner
University of Applied Sciences, Rheinbach, Germany
Clin Lab 51:243-9. 2005..sample for HbA1c measurement, is increasing the probability of the acceptance of this marker for routine assessment of beta-cell dysfunction and insulin resistance in type 2 diabetes...
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer studyAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Parcusstrasse 8, D 55116 Mainz, Germany
J Am Coll Cardiol 45:1925-31. 2005..This study was performed to assess whether the anti-inflammatory and antiatherogenic effects of pioglitazone suggested by animal experiments are reproducible in man and independent from improvements in metabolic control...
IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study designAndreas Pfutzner
University of Applied Sciences, Rheinbach, Germany
Diabetes Technol Ther 7:478-86. 2005..The cross-sectional IRIS-II study tried to assess the prevalence of insulin resistance and macrovascular disease in orally treated patients with Type 2 diabetes...
Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace studyAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:989-98. 2011..This study investigated the effects of pioglitazone (PIO), ramipril (RAM), or their combination (PIRA) on low-grade inflammation in nondiabetic hypertensive patients with increased cardiovascular risk...
[Pitfalls in the diagnosis and treatment optimization of type 2 diabetes]A Pfutzner
Institut für klinische Forschung und Entwicklung Mainz
MMW Fortschr Med 147:47-50. 2005..New biochemical markers such as adiponectin and intact proinsulin may facilitate treatment decisions and monitoring in patients with type 2 diabetes...
[Practical diagnosis in insulin resistance and beta-cell dysfunction and resulting therapeutic consequences]A Pfutzner
Fachhochschule Bonn Rhein Sieg, Rheinbach
MMW Fortschr Med 146:32-3, 35. 2004
Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot studyPetra B Musholt
Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 3:1442-50. 2009..The aim of our study was to examine the efficacy of short-term intravenous insulin intervention followed by oral pioglitazone/metformin therapy to prevent patients from continuous insulin application...
IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistanceMatthias R Langenfeld
IKFE Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:836-43. 2004....
Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial stateClothilde Hohberg
Institute for Clinical Research and Development, Parcusstrasse 8, D 55116 Mainz, Germany
Diabetes Care 31:1021-5. 2008..To investigate the effect of insulin glulisine on postprandial microvascular blood flow in type 2 diabetes...
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular riskThomas Forst
Medical Director, Institute for Clinical Research and Development, Mainz, Germany
Diab Vasc Dis Res 5:298-303. 2008..05 respectively). Atorvastatin significantly improved IMT and vascular elasticity. Co-administration of pioglitazone provided additional effects on endothelial function, lipid profile and laboratory markers of inflammation...
Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitusThomas Forst
Institute for Clinical Research and Development, University of Mainz, Germany
Clin Sci (Lond) 119:345-51. 2010..47; P<0.05). This is the first study showing an improvement in EI during treatment with PIO, which was associated with an increase in adiponectin and a decrease in intact proinsulin levels, but independent of glycaemic control...
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix studyThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:426-32. 2011..This study investigates the impact of a pioglitazone plus metformin therapy on biomarkers of inflammation and platelet activation in comparison to a treatment with glimepiride plus metformin...
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT StudyThomas Forst
Institute for Clinical Research and Development, Medical Department, D 55116 Mainz, Germany
Metabolism 56:491-6. 2007..05) during PIO/SIM treatment. Lipid parameters improved during SIM treatment but not during PIO treatment. Combined treatment with PIO/SIM was superior in improving overall cardiovascular risk profile than every single drug...
Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen deviceThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 11:87-92. 2009....
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitusThomas Schondorf
Institute of Clinical Research and Development, Mainz, Germany
Clin Lab 53:193-8. 2007..In women, other pathways may superimpose this effect. In conclusion, our study supports the hypothesis of different regulating pathways and effects of relaxin in men and women also in patients with type 2 diabetes...
Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2Thomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Microcirculation 12:543-50. 2005..The study was performed to investigate the effect of improving metabolic control with pioglitazone in comparison to glimepiride on microvascular function in patients with diabetes mellitus type 2...
Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetesThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Care 33:116-20. 2010..This study compared the effect of VIAject with human regular insulin and insulin lispro on postprandial oxidative stress and endothelial function in patients with type 2 diabetes...
Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitusChristina Schipper
IKFE Institute for Clinical Research and Development, Mainz, Germany
Curr Med Res Opin 28:1297-303. 2012..The aim of this study was to evaluate patient perception of FT versus IL (InnoLet†) with respect to the ease of use and patient preference in a mixed patient cohort with different kinds and degrees of visual or dexterity impairments...
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditionsThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 11:379-83. 2009....
Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetesTanja Reimer
Institute for Clinical Research and Development GmbH, Mainz, Germany
Clin Ther 30:2252-62. 2008..Because the use of insulin therapy can place a substantial burden on patients with diabetes, insulin administration should be as simple as possible...
Elevated peripheral visfatin levels in narcoleptic patientsNorbert Dahmen
Department of Psychiatry, University of Mainz, Mainz, Germany
PLoS ONE 3:e2980. 2008..Visfatin is a recently described proinflammatory adipokine. It is identical to the immune modulating pre-B-cell colony enhancing factor (PBEF). Our study examines the hypothesis that visfatin levels are altered in narcoleptic patients...
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistanceAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 50:567-73. 2004..Both assays can thus be used to assess beta-cell function, to facilitate the selection of the most promising therapy, and may also serve to monitor treatment success in the further course of the disease...
Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetesThomas Forst
Institute for Clinical Research and Development, Parcusstrasse 8, Mainz D 55116, Germany
J Diabetes Complications 19:128-32. 2005..0 (19.0-49.3) vs. 20.9 (9.7-26.1) AU, P=.0001]. Postprandial microvascular blood flow is disturbed in patients with Type 1 diabetes. Improvement of postprandial metabolic control was found to improve postprandial microvascular function...
Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3Volkmar Schmid
IKFE CRO, Mainz, Germany
J Diabetes Sci Technol 4:976-82. 2010....
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA studyThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
Diab Vasc Dis Res 7:145-50. 2010..Patients with diabetes mellitus and IGT have a high risk for cardiovascular events. It is tempting to speculate that these patients are often first seen by cardiologists...
Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCRMarion Lorenz
Institute for Clinical Research and Development ikfe GmbH, Mainz, Germany
Clin Lab 58:959-71. 2012..Development of a fast and reliable real-time PCR application for TPMT genotyping would greatly improve thiopurine treatment regimens and allow the avoidance of adverse drug reactions...
Evaluation of dexterity in insulin-treated patients with type 1 and type 2 diabetes mellitusJulia Pfützner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:158-65. 2011..Dexterity skills may play an important role in the performance efficacy of these procedures...
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitusThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 6:163-8. 2012..The aim of this study was to investigate early morphological and functional pathology in the retinal micro-circulation in patients with insulin resistance and/or type 2 diabetes mellitus (T2DM)...
Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the testsMichael Safinowski
Institute for Clinical Research and Development, Mainz, Germany
Clin Chem Lab Med 47:483-8. 2009..The peroxynitrite concentrations can be indirectly monitored by the detection of nitrotyrosine residues in proteins, reflecting the extent of damage caused by oxidative stress...
Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic controlThomas Forst
Institute for Clinical Research and Development, 55116 Mainz, Germany
Exp Diabetes Res 2012:635472. 2012....
Comparison of the dose accuracy of prefilled insulin pensAlexander Weise
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 3:149-53. 2009..This study compared the dosing accuracy of two prefilled insulin pens (the SoloStar((R)) from Sanofi Aventis, Berlin, Germany, and the Next Generation [NG] FlexPen((R)) from Novo Nordisk, Mainz, Germany)...
Review of approved pioglitazone combinations for type 2 diabetesThomas Forst
IKFE Institute for Clinical Research and Development, Parcusstr 8, D 5116 Mainz, Germany
Expert Opin Pharmacother 12:1571-84. 2011..The treating of T2DM patients by addressing not only glucose control, but also the underlying pathophysiological etiology might help to improve patient prognosis in the long run, especially with regard to the vascular complications...
Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?Marco Klemm
PharmGenomics GmbH, Mainz, Germany
Clin Lab 56:473-80. 2010....
Downregulation of the proinflammatory state of circulating mononuclear cells by short-term treatment with pioglitazone in patients with type 2 diabetes mellitus and coronary artery diseaseAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Research Laboratory, 55116 Mainz, Germany
PPAR Res 2011:647017. 2011....
Assessment of the mixing efficiency of neutral protamine Hagedorn cartridgesPia Kaiser
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 4:652-7. 2010..All other cartridges with fewer bullets were shown to deliver potentially harmful doses if used for treatment when the mixing procedure was less frequent than demanded in the instructions for use...
Laboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammationRenate Siebenhaar
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 4:717-22. 2010..It may therefore be suitable for a fast and convenient screening, which, after laboratory test confirmation, may help to identify patients with elevated risk of macrovascular disease...
Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetesBirgit Wilhelm
Institute for Clinical Research and Development, Johannes Gutenberg University, Mainz, Germany
Diabetes Technol Ther 8:146-55. 2006..CONCLUSIONS: Continuous glucose measurements using CGMS provide reliable glucose measurements even in the case of dynamic blood glucose changes...
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic painThomas Forst
Institute for Clinical Research and Development and Department of Endocrinology, University of Mainz, Mainz, Germany
Br J Clin Pharmacol 64:75-82. 2007..The purpose of the current study was to establish the safety and maximal tolerated dose of CNS 5161 HCl...
Dynamic electrochemistry corrects for hematocrit interference on blood glucose determinations with patient self-measurement devicesPetra B Musholt
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:1167-75. 2011..The purpose of this laboratory investigation was to assess the potential influence of hematocrit variations on a variety of blood glucose meters applying different measurement technologies...
Peripheral leptin levels in narcoleptic patientsNorbert Dahmen
Department of Psychiatry, University of Mainz, Mainz, Germany
Diabetes Technol Ther 9:348-53. 2007..Two studies have reported decreased leptin levels, whereas a larger, recent study failed to detect differences between patients and controls...
Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathyMai Nguyen
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:601-6. 2004..82; vibration = 0.61; temperature = 0.42; light touch = 0.11). CONCLUSIONS: Measurement of pain perception threshold using the SET device is an easy and reliable method for identifying patients with impaired small nerve fiber function...
Biological background and role of adiponectin as marker for insulin resistance and cardiovascular riskThomas Schondorf
University of Applied Science, Dept of Applied Natural Sciences, Rheinbach, Germany
Clin Lab 51:489-94. 2005..This review summarizes recent biological and clinical data indicating that adiponectin may be the molecular link between obesity and insulin resistance and may serve as a biomarker for the metabolic syndrome...
Stimulation of endothelial nitric oxide synthase by proinsulin C-peptideThomas Wallerath
Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany
Nitric Oxide 9:95-102. 2003..We suggest that this effect may contribute to the increase in skin and muscle blood flow previously demonstrated in human in vivo...
